Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Virology ; 510: 234-241, 2017 10.
Artículo en Inglés | MEDLINE | ID: mdl-28750327

RESUMEN

Cholesterol-rich lipid raft microdomains in the plasma membrane are considered to play a major role in the enveloped virus lifecycle. However, the functional role of cholesterol in assembly, infectivity and stability of respiratory RNA viruses is not fully understood. We previously reported that depletion of cellular cholesterol by cholesterol-reducing agents decreased production of human parainfluenza virus type 1 (hPIV1) particles by inhibiting virus assembly. In this study, we analyzed the role of cholesterol on influenza A virus (IAV) and respiratory syncytial virus (RSV) production. Unlike hPIV1, treatment of human airway cells with the agents did not decrease virus particle production. However, the released virions were less homogeneous in density and unstable. Addition of exogenous cholesterol to the released virions restored virus stability and infectivity. Collectively, these data indicate a critical role of cholesterol in maintaining IAV and RSV membrane structure that is essential for sustaining viral stability and infectivity.


Asunto(s)
Colesterol/metabolismo , Virus de la Influenza A/fisiología , Virus Sincitiales Respiratorios/fisiología , Ensamble de Virus , Humanos , Viabilidad Microbiana , Virión/metabolismo , Virión/ultraestructura
2.
Virology ; 501: 127-135, 2017 01 15.
Artículo en Inglés | MEDLINE | ID: mdl-27915128

RESUMEN

Many enveloped RNA viruses utilize lipid rafts for the assembly of progeny virions, but the role of cholesterol, a major component of rafts, on paramyxovirus budding and virion formation is controversial. In this study, we analyzed the effects of FDA-approved cholesterol-reducing agents, gemfibrozil and lovastatin, on raft formation and assembly of human parainfluenza virus type 1 (hPIV1) and Sendai virus (SeV). Treatment of the human airway epithelial A549 cells with the agents, especially when combined, significantly decreased production of infectious hPIV1 and SeV. Mechanistic analysis indicated that depletion of cellular cholesterol reduced cell surface accumulation of envelope glycoproteins and association of viral matrix and nucleocapsids with raft membrane, which resulted in impaired virus budding and release from the cells. These results indicate that cellular cholesterol is required for assembly and formation of type 1 parainfluenza viruses and suggest that cholesterol could be an attractive target for antiviral agents against hPIV1.


Asunto(s)
Anticolesterolemiantes/farmacología , Colesterol/metabolismo , Virus de la Parainfluenza 1 Humana/efectos de los fármacos , Infecciones por Paramyxoviridae/virología , Ensamble de Virus/efectos de los fármacos , Membrana Celular/metabolismo , Membrana Celular/virología , Humanos , Virus de la Parainfluenza 1 Humana/genética , Virus de la Parainfluenza 1 Humana/fisiología , Infecciones por Paramyxoviridae/tratamiento farmacológico , Infecciones por Paramyxoviridae/metabolismo , Transporte de Proteínas , Proteínas Virales/genética , Proteínas Virales/metabolismo , Liberación del Virus/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA